10-Q: SkyTech Orion Shifts to Defense Drones, Secures Israeli Grant
Quarterly Report
SkyTech Orion Global Corp., formerly Citrine Global, announced a strategic pivot to defense-grade UAV and drone solutions, securing a NIS 12.5 million government grant for its new innovation center in Israel.
Summary
- Citrine Global Corp. has officially changed its name to SkyTech Orion Global Corp. in Delaware, reflecting a strategic pivot from wellness and plant-based health to defense-grade Unmanned Systems (UMS) and drone solutions.
- Its Israeli subsidiary, Cannovation Center Israel Ltd., also changed its name to SkyTech Orion Ltd. on May 13, 2025.
- The company was selected by the Government of Israel to lead a national project in the military UMS and drone sector, receiving a NIS 12.5 million (approximately $3.4 million) development grant from the Israeli Ministry of Economy and Industry on January 12, 2025.
- This grant supports the establishment of the SkyTech Innovation and Production Center in Yerucham, Israel, a 5,000 square meter facility on company-owned land, focused on R&D, assembly, testing, and production of defense-grade UAV and drone solutions.
- The company reported a net loss of $267,000 for the three months ended March 31, 2025, compared to a net loss of $252,000 for the same period in 2024.
- Operating loss improved to $238,000 in Q1 2025 from $403,000 in Q1 2024, primarily due to decreased marketing, general, and administrative expenses.
- Cash and cash equivalents increased significantly to $67,000 as of March 31, 2025, from $1,000 at December 31, 2024, driven by $123,000 in cash provided by financing activities.
- The company's working capital deficiency increased to $3,542,000 as of March 31, 2025, from $3,464,000 at December 31, 2024.
- A credit facility with S.R. Accord Ltd. was increased to NIS 1,000,000 (approximately $280,000) on March 31, 2025, and extended until March 31, 2027, supported by personal guarantees from the CEO and a director, with company indemnification.
- Deer Light Ltd. invested $138,000 for 13.7 million common shares and 13.7 million warrants, with the investment fully completed by March 31, 2025.
- The company recorded an impairment loss of approximately $431,000 on its investment in Nanomedic Technologies Ltd. following a financing round by Nanomedic on June 3, 2025.
Sentiment
Score: 7
Explanation: The company has made a significant and potentially transformative strategic pivot into the high-growth defense UAV and drone sector, backed by a substantial Israeli government grant and a clear roadmap for establishing a national innovation center. This shift, coupled with an improved operating loss and increased cash, indicates strong positive momentum in its new direction. However, the company continues to report a net loss, an increasing working capital deficiency, and has acknowledged ineffective disclosure controls, which are areas of concern. The impairment loss on the Nanomedic investment also reflects a past misstep. The overall sentiment is cautiously optimistic due to the strategic realignment and government support, despite ongoing financial challenges and operational risks.
Positives
- Successful strategic pivot to the high-growth defense-grade UAV and drone sector, aligning with national priorities in Israel.
- Awarded a significant NIS 12.5 million (approximately $3.4 million) government grant from the Israeli Ministry of Economy and Industry for the SkyTech Innovation and Production Center.
- Received complementary government benefits including corporate tax incentives, employment support, and regulatory guidance for the new defense focus.
- Operating loss improved, decreasing to $238,000 for Q1 2025 from $403,000 in Q1 2024.
- Cash and cash equivalents increased substantially to $67,000 as of March 31, 2025, from $1,000 at December 31, 2024.
- Secured an investment of $138,000 from Deer Light Ltd. for shares and warrants.
- Credit facility with S.R. Accord Ltd. was increased to NIS 1,000,000 (approximately $280,000) and extended until March 31, 2027, providing liquidity.
- Development of a unique multi-domain modular system for unmanned platforms, utilizing Western defense-grade components, positioning for significant sales potential.
- Strategic alignment with U.S. defense procurement policies and evaluation of a U.S.-based production center for global expansion.
- Resolution of a legal issue with a former consultant of Cannovation Center Israel Ltd. through a binding settlement agreement.
Negatives
- Net loss increased to $267,000 for the three months ended March 31, 2025, compared to $252,000 for the same period in 2024.
- Working capital deficiency increased to $3,542,000 as of March 31, 2025, from $3,464,000 at December 31, 2024.
- Net cash used in operating activities increased to $57,000 for Q1 2025 from $45,000 for Q1 2024.
- The company has not generated any revenues from product sales as of March 31, 2025.
- Recorded a significant impairment loss of approximately $431,000 on its investment in Nanomedic Technologies Ltd.
- Disclosure controls and procedures were deemed not effective as of March 31, 2025.
- The war in Israel caused material delays in wellness-related product development, fundraising, and marketing efforts, preventing the execution of strategic plans in that sector.
- The company is incurring losses and cannot determine with reasonable certainty when it will achieve sustainable profits.
- Golden Holdings Finance's stake in Cannovation was diluted to approximately 1% due to its failure to provide support or personal guarantees.
Risks
- Risks Relating to Israel Operations: The company's headquarters, executive management, and subsidiaries are based in Israel, making its results susceptible to adverse effects from economic restrictions, political, and current military events.
- Geopolitical Instability: The ongoing war in Israel (since October 7, 2023) creates widespread uncertainty and instability, disrupting the Israeli economy and potentially causing significant long-term consequences for business activities, including supply chain disruptions, operational continuity, or access to resources.
- Uncertainty of Sustainable Profits: The company is currently incurring losses and cannot determine with reasonable certainty when and if it will achieve sustainable profits.
- Regulatory Compliance for New Sector: The transition into the defense and aerospace sector, particularly UAVs and drones, operates under a distinct and stringent regulatory framework in Israel (Ministry of Defense, Directorate of Security for the Defense Establishment, Export Control Agency) and internationally (NDAA, ITAR, EU defense/export regulations), requiring ongoing compliance and certifications.
- Development Agreement Obligations: The development agreement for the industrial land in Yerucham requires development within four years (with possible extensions), and failure to meet these terms could impact the long-term lease rights.
- Reliance on Personal Guarantees: The company's credit facilities and bank guarantees are significantly backed by personal guarantees from its CEO, Ora Elharar Soffer, and director Lior Asher, which, despite indemnification, represents a concentration of personal financial risk.
- Ineffective Disclosure Controls: The company's disclosure controls and procedures were concluded to be not effective as of March 31, 2025, which could lead to reporting inaccuracies or delays.
- Market Value of Collateral: If the market value of the industrial land in Yerucham falls below the outstanding amount of the credit facility, the lender may be entitled to additional security, including shares of Citrine Global common stock.
- Competition: The defense UAV and drone market is rapidly evolving and competitive, requiring continuous innovation and compliance with stringent standards.
Future Outlook
The company anticipates continued losses as it embarks on its new business plan in the defense and UMS sector, with no certainty regarding when sustainable profits will be achieved. It expects to incur ongoing research and development expenses for several years. The company believes it has sufficient funds for the next twelve months due to current cash balances and access to its extended credit facility. It plans for large-scale commercial sales across key defense markets, including the Israeli defense sector, international allied markets, and the U.S. military, and is evaluating establishing a U.S.-based production and assembly center. The vision is to produce hundreds of thousands of FPV drones annually at the SkyTech Center.
Management Comments
- "Based on our current cash balances, and the access to the Credit Facility noted above, we believe we will have sufficient funds for our plans for the next twelve months from the issuance of these financial statements."
- "As we are embarking on our business plan, we are incurring losses. We cannot determine with reasonable certainty when and if we will have sustainable profits."
- "Management determined that the existing wellness-focused strategy was no longer sufficient to drive growth. The Company therefore resolved to broaden its scope of activity and prepare for expansion into additional areas of development."
- "SkyTech believes that close collaboration with Israels defense system provides a significant advantage in aligning product development with real-world operational needs, accelerating time-to-field, and ensuring that its platforms meet the highest military and regulatory standards."
- "SkyTechs vision is that, as part of the infrastructure being developed within the SkyTech Center, the company will have the capability to produce hundreds of thousands of FPV drones annually."
Industry Context
The company's strategic pivot into the defense-grade UAV and drone industry aligns with significant global trends, particularly the escalating demand for advanced unmanned systems driven by modern conflicts like those in Ukraine and Israel. The filing highlights market projections for aerial systems to reach $163.6 billion by 2030 and the small drones market to grow from $6.4 billion in 2025 to $11.25 billion by 2030, underscoring a robust and expanding market. The emphasis on Western-approved components and compliance with regulations like NDAA and ITAR reflects a broader industry shift towards secure, reliable supply chains and away from restricted-origin technologies, especially in defense. Israel's national prioritization of the UAV and drone sector, coupled with substantial government investment and a supportive regulatory environment, provides a strong foundation for companies like SkyTech Orion, positioning it within a globally recognized innovation hub for defense technologies.
Comparison to Industry Standards
- The company's vision to produce "hundreds of thousands of FPV drones annually" at the SkyTech Center is ambitious and, if achieved, would position it as a significant player in the tactical small drones market, which currently sees demand surpassing one million units per year in conflicts like Ukraine.
- The focus on "certified, military-grade components designed to meet the highest defense standards" and compliance with "NDAA, ITAR, and Israeli MOD requirements" indicates an adherence to stringent global benchmarks for defense technology, comparable to leading defense contractors.
- The establishment of a "national hub for innovation and manufacturing in the field of unmanned systems (UMS)" in Yerucham, Israel, leverages Israel's established reputation as a leader in defense technology and innovation, similar to how other nations foster defense tech clusters.
- The company's dual-national structure, aiming for a U.S.-based production center, directly addresses "U.S. defense procurement policies and regulatory frameworks" and the "Made in USA compliance" requirements, mirroring strategies of international defense companies seeking to access the lucrative U.S. defense market.
- The reported Israeli defense exports of $14.79 billion in 2024, with over 54% to Europe, demonstrate a strong national performance that SkyTech Orion aims to contribute to, aligning with the success of established Israeli defense companies.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Personal Guarantor (SR Accord Loan) | NA | Lior Asher | 2024-09-01 | Joined Ora Elharar Soffer as guarantor for the renewed short term loan. |
| Personal Guarantor (Bank Mizrahi Guarantee) | NA | Meir Aharon | 2025-04-08 | Provided limited personal guarantee for government grant requirements; engaged to build SkyTech Center. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Name Change | Citrine Global Corp. changed its name to SkyTech Orion Global Corp. in Delaware, reflecting a strategic focus on UAV and drone solutions. | 2025-06-26 | Aligns corporate identity with new strategic direction, potentially enhancing market perception and facilitating access to defense sector opportunities. |
| Subsidiary Name Change | Cannovation Center Israel Ltd. changed its name to SkyTech Orion Ltd. | 2025-05-13 | Aligns subsidiary identity with new strategic direction, supporting brand consistency and market positioning in the UAV/drone sector. |
| Equity Reallocation | Following Golden Holdings Finance's failure to provide support, shares in Cannovation were reallocated, increasing CTGL Citrine Global Israel Ltd.'s holdings to 69.5% and Beezhome Technologies Ltd.'s to 29.5%, diluting Golden Holdings Finance to approximately 1%. | 2025-05-29 | Consolidates control within the company and its CEO's entity, potentially streamlining decision-making and ensuring commitment from key stakeholders, but also reduces external minority shareholder stake. |
| D&O Insurance Policy | Approved a Directors & Officers (D&O) insurance policy with coverage of USD 3 million at an annual premium of USD 23,750. | 2025-03-05 | Provides protection for directors and officers against potential liabilities, enhancing governance and potentially attracting/retaining qualified board members. |
| Share Capital Increase Approval | Board approved to increase the share capital of Cannovation Center Israel Ltd. and CTGL Citrine Global Israel Ltd. | 2025-03-26 | Provides flexibility for future equity financing or strategic transactions within the subsidiaries, supporting growth initiatives. |
| Anti-Dilution Protection | Granted Anti-Dilution Protection to Beezhome Technologies Ltd. (wholly owned by Ms. Ora Elharar Soffer) with respect to its holdings in SkyTech Orion Ltd., in recognition of her continuous support and personal financial exposure. | 2025-06-19 | Incentivizes and protects the CEO's significant personal investment and commitment, but could potentially impact other shareholders' future dilution if not carefully managed. |
| Disclosure Controls and Procedures | Management concluded that the company's disclosure controls and procedures are not effective as of March 31, 2025. | 2025-03-31 | Indicates a material weakness in internal controls, potentially leading to risks of misstatement in financial reporting and non-compliance with SEC regulations, requiring immediate remediation efforts. |
Legal Proceedings
- A past issue involving a former consultant of Cannovation Center Israel Ltd. relating to management fees and compensation for the notice period has been fully resolved through a binding Settlement Agreement.
- As of the filing date, the company is not aware of any other legal proceedings involving the company and/or its subsidiaries.
Related Party Transactions
- Research and development expenses with related parties totaled $32,000 for the three months ended March 31, 2025.
- Marketing, general and administrative expenses with related parties totaled $165,000 for the three months ended March 31, 2025.
- Share-based compensation with related parties totaled $31,000 for the three months ended March 31, 2025.
- Accounts payable to related parties amounted to $324,000 as of March 31, 2025.
- Accrued compensation to related parties amounted to $2,524,000 as of March 31, 2025.
- Convertible notes with related parties amounted to $711,000 as of March 31, 2025.
- Consulting agreements with Deer Light Ltd. (controlled by Mr. Lior Asher, a director) involve total monthly retainer fees of USD 11,000, deferred until a payment event.
- An equity grant of options to purchase 41,762,976 common shares was approved for Deer Light Ltd. (Mr. Lior Asher), though not yet issued.
- Deer Light Ltd. (Mr. Lior Asher) invested USD 138,000 for 13.7 million common shares and 13.7 million warrants.
- Personal guarantees for the S.R. Accord Ltd. credit facility were provided by Ms. Ora Elharar Soffer (CEO) and Mr. Lior Asher (director), with the company undertaking full indemnification.
- Personal guarantees for the Bank Mizrahi digital bank guarantee were provided by Ms. Ora Elharar Soffer (unlimited) and Mr. Meir Aharon (limited), with the company undertaking full indemnification.
- A contract was signed with M. Aharon Construction & Projects Ltd. (Mr. Meir Aharon) for the construction of the SkyTech Center, including a bonus (options) and indemnification.
- Beezhome Technologies Ltd. (wholly owned by Ms. Ora Elharar Soffer) holds 29.5% of SkyTech Orion Ltd. and was granted Anti-Dilution Protection.
Stakeholder Impact
- Shareholders: The strategic pivot to defense-grade UAVs and drones, backed by government grants, could significantly enhance long-term shareholder value by tapping into a high-growth, high-demand sector. However, the increased net loss, working capital deficiency, and ineffective disclosure controls present risks. The dilution of Golden Holdings Finance and the anti-dilution protection for Beezhome (CEO's entity) could be viewed differently by various shareholder groups.
- Employees: The establishment of the SkyTech Innovation and Production Center in Yerucham, Israel, and potential U.S. expansion, is expected to create new jobs in R&D, manufacturing, and related fields, particularly in a strategic national priority zone.
- Customers (Defense Sector): The company aims to provide advanced, regulation-compliant, Western-grade UAV and drone solutions to the Israeli defense sector, international allied markets, and the U.S. military, addressing critical operational needs and strengthening defense capabilities.
- Suppliers: The focus on using Western-approved components for its modular systems will likely create opportunities for suppliers of such components, while the construction of the SkyTech Center will involve construction and equipment suppliers.
- Creditors: The extension of the credit facility and the provision of personal guarantees, along with company indemnification, provide some assurance to creditors, but the ongoing losses and working capital deficiency indicate continued reliance on financing.
- Government (Israel): The company's activities directly support Israel's national strategic program for defense, UMS, and drone innovation, contributing to technological independence, national production capabilities, and economic development in priority regions like Yerucham.
Next Steps
- Continue to develop products and innovative solutions in the defense-grade UAV and drone sector.
- Advance regulatory and certification processes required to enter defense markets (Israeli MOD, MALMAB, export control, NDAA, ITAR, EU defense/export regulations).
- Complete the permitting phase and submit final detailed engineering and construction plans for the SkyTech Innovation and Production Center in Yerucham.
- Establish initial assembly capabilities through a hybrid model combining in-house resources with strategic collaborations with certified contractors.
- Evaluate localized manufacturing options and establish a U.S.-based production and assembly center.
- Prepare for large-scale commercial sales across key defense markets, including the Israeli defense sector, international allied markets, and the U.S. military.
- Assess how wellness-related assets (equity stakes in iBOT and MyPlant, proprietary formulations) can be realized or leveraged in the future.
- Continue to monitor the evolving regional situation in Israel and its potential impact on business activities.
- Address the ineffectiveness of disclosure controls and procedures.
- Recognize unrecognized compensation cost related to non-vested options over a weighted average period of 0.5 years.
Key Dates
| Date | Description |
|---|---|
| 2010-05-26 | Citrine Global, Corp. incorporated under the laws of the State of Delaware. |
| 2020-06-03 | Company established wholly owned Israeli subsidiary: CTGL Citrine Global Israel Ltd. |
| 2020-08-20 | Israeli Subsidiary, Beezhome Technologies Ltd., and Golden Holdings Neto Ltd. incorporated Cannovation Center Israel Ltd. |
| 2022-02-01 | Cannovation Center Israel Ltd. acquired approximately 11,687 square meters of industrial land in Yerucham, Israel. |
| 2023-03-05 | Board determined that half of awarded but unvested option grants would immediately vest upon Nasdaq listing, and a one-year exercise period for vested options post-termination. |
| 2023-03-06 | Cannovation and S.R. Accord Ltd. entered into an 18-month credit facility agreement for NIS 3,000,000 (approximately $857,000). |
| 2023-10-07 | Large-scale war broke out in Israel, leading to a prolonged national crisis and affecting company operations. |
| 2024-09-01 | Deer Light Ltd. entered into consulting agreements with the Company and its subsidiaries for strategic planning, business development, and project management services. |
| 2024-09-01 | Company renewed its short term loan with S.R. Accord Ltd. in the amount of approximately NIS 660,000 (approximately $176,000). |
| 2024-12-31 | Management determined existing wellness-focused strategy was no longer sufficient and resolved to broaden scope into defense and UMS. |
| 2025-01-07 | Deer Light Ltd. signed an investment agreement with Citrine Global Corp. to invest USD 138,000 for 13.7 million common shares and 13.7 million warrants. |
| 2025-01-12 | Cannovation Center Israel Ltd. received official notification of a government grant of NIS 12.5 million (approximately USD 3.4 million) for the SkyTech Innovation and Production Center. |
| 2025-01-23 | Shareholders meeting of Cannovation Center Ltd. held, where CTGL Citrine Global Israel Ltd. and Beezhome Technologies Ltd. provided support and personal guarantees. |
| 2025-03-05 | Board approved a Directors & Officers (D&O) insurance policy with coverage of USD 3 million. |
| 2025-03-15 | Deadline for Deer Light Ltd. investment completion (fully remitted by March 31, 2025). |
| 2025-03-26 | Board approved to increase the share capital of Cannovation Center Israel Ltd. and CTGL Citrine Global Israel Ltd. |
| 2025-03-31 | Total amount of the short term loan with S.R. Accord Ltd. increased to NIS 1,000,000 (approximately $280,000). |
| 2025-03-31 | End of the quarterly reporting period. |
| 2025-04-08 | Digital bank guarantee in the amount of NIS 625,000 (approximately $187,000 USD) issued by Bank Mizrahi for the government grant requirements. |
| 2025-04-08 | Contract signed with M. Aharon Construction & Projects Ltd. for the construction of the concrete skeleton of the SkyTech Center. |
| 2025-05-13 | Israeli subsidiary Cannovation Center Israel Ltd. changed its name to SkyTech Orion Ltd. |
| 2025-05-29 | Company executed resolution to reallocate shares in Cannovation, increasing CTGL Citrine Global Israel Ltd.'s holdings to 69.5% and Beezhome Technologies Ltd.'s to 29.5%, diluting Golden Holdings Finance to approximately 1%. |
| 2025-06-03 | Nanomedic Technologies Ltd. completed a financing round of approximately $3,000,000, leading to an impairment loss for the Company. |
| 2025-06-19 | Board of Directors of SkyTech Orion Ltd. approved the rental of a temporary facility for assembly activities. |
| 2025-06-19 | Anti-Dilution Protection granted to Beezhome Technologies Ltd. (wholly owned by Ms. Ora Elharar Soffer) with respect to its holdings in SkyTech Orion Ltd. |
| 2025-06-26 | Citrine Global Corp. changed its name to SkyTech Orion Global Corp. in Delaware. |
| 2025-06-30 | Carrying amount of investment in Nanomedic Technologies Ltd. was approximately $18,000 after impairment loss. |
| 2025-08-01 | SR Accord extended the credit facility agreement with Cannovation Center Israel Ltd. (renamed SkyTech Orion Ltd.) until March 31, 2027. |
| 2025-08-31 | Filing date of Annual Report on Form 10-K for the fiscal year ended December 31, 2024. |
| 2025-09-03 | Filing date of this Quarterly Report on Form 10-Q. |
Recommendation
strong buyThe strategic pivot to the defense-grade UAV and drone sector, coupled with a substantial NIS 12.5 million (approximately $3.4 million) government grant and the establishment of a national innovation center in Israel, represents a highly transformative and positive development. This move aligns the company with a rapidly growing and critically important global market, particularly given current geopolitical dynamics. While the company still reports a net loss and a working capital deficiency, the significant improvement in operating loss, increased cash from financing, and the clear strategic direction with strong government backing outweigh these short-term financial challenges. The potential for large-scale commercial sales to defense sectors in Israel, the U.S., and allied markets, along with the development of proprietary modular systems using Western-grade components, positions the company for substantial future growth. The acknowledged ineffective disclosure controls are a concern, but the overall strategic shift and secured funding indicate a strong long-term upside for a seasoned investor willing to accept the inherent risks of an early-stage defense tech company.
Keywords
UAV, Drones, Defense Technology, Unmanned Systems, Israel, Yerucham, SkyTech Orion, Government Grant, Strategic Shift, Financial Reporting, SEC Filing, Aerospace, Military Technology, FPV Drone, Manufacturing, R&D, Corporate Governance, Financial Performance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.